| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
GIMV NV (BR: GIMB)
GIMB Technical Analysis
3
| As on 28th Mar 2025 GIMB STOCK Price closed @ 39.95 and we RECOMMEND Sell for LONG-TERM with Stoploss of 42.89 & Sell for SHORT-TERM with Stoploss of 41.47 we also expect STOCK to react on Following IMPORTANT LEVELS. |
GIMBSTOCK Price
| Open | 39.95 | Change | Price | % |
| High | 40.05 | 1 Day | 0.25 | 0.63 |
| Low | 39.75 | 1 Week | 0.85 | 2.17 |
| Close | 39.95 | 1 Month | 2.60 | 6.96 |
| Volume | 32213 | 1 Year | 0.90 | 2.30 |
| 52 Week High 46.80 | 52 Week Low 35.85 | ||||
BR Belgium Most Active Stocks
| SCHD | 27.59 | -91.89% |
| ABI | 57.72 | 0.80% |
| BOTHE | 0.29 | 70.59% |
| ACPH | 0.89 | 0.00% |
| KBC | 85.00 | -3.26% |
| UMI | 10.15 | 1.70% |
| PROX | 6.84 | 2.09% |
| UCB | 164.35 | -1.08% |
| AGS | 55.75 | -0.71% |
| ELI | 81.75 | -0.30% |
BR Belgium Top Gainers Stocks
BR Belgium Top Losers Stocks
| GIMB Daily Charts |
GIMB Intraday Charts |
Whats New @ Bazaartrend |
GIMB Free Analysis |
|
|
GIMB Important Levels Intraday
| RESISTANCE | 40.53 |
| RESISTANCE | 40.34 |
| RESISTANCE | 40.23 |
| RESISTANCE | 40.11 |
| SUPPORT | 39.79 |
| SUPPORT | 39.67 |
| SUPPORT | 39.56 |
| SUPPORT | 39.37 |
GIMB Forecast March 2025
| 4th UP Forecast | 46.5 |
| 3rd UP Forecast | 44.4 |
| 2nd UP Forecast | 43.1 |
| 1st UP Forecast | 41.8 |
| 1st DOWN Forecast | 38.1 |
| 2nd DOWN Forecast | 36.8 |
| 3rd DOWN Forecast | 35.5 |
| 4th DOWN Forecast | 33.4 |
GIMB Weekly Forecast
| 4th UP Forecast | 45.83 |
| 3rd UP Forecast | 43.94 |
| 2nd UP Forecast | 42.78 |
| 1st UP Forecast | 41.61 |
| 1st DOWN Forecast | 38.29 |
| 2nd DOWN Forecast | 37.12 |
| 3rd DOWN Forecast | 35.96 |
| 4th DOWN Forecast | 34.07 |
GIMB Forecast2025
| 4th UP Forecast | 61.63 |
| 3rd UP Forecast | 54.68 |
| 2nd UP Forecast | 50.38 |
| 1st UP Forecast | 46.08 |
| 1st DOWN Forecast | 33.82 |
| 2nd DOWN Forecast | 29.52 |
| 3rd DOWN Forecast | 25.22 |
| 4th DOWN Forecast | 18.27 |
GIMV NV ( BR Belgium Symbol : GIMB )
Sector : Financial Services And Other Stocks in Same Sector
Sector : Financial Services And Other Stocks in Same Sector
GIMB Business Profile
GIMV NV is a private equity and venture capital firm specializing in direct and fund of funds investments. For direct investments, the firm specializes in buyouts, growth capital, middle market, debt, shareholder loans, seed, startups, early to mid-stage, late venture, public to private transactions, small and medium sized enterprises, later stage, mature, replacement capital, bridge financing, and recapitalization. Within fund of funds, it seeks to invest in venture capital and private equity funds. It seeks to invest in high performance growth companies that respond to that can speed up their internal growth through acquisitions. The firm typically invests in consumer 2020; Connected Consumer, fintech; health and care; smart industries; and sustainable cities. Within consumer 2020, it seeks to provide growth capital to emerging leaders. Within health and care platform, the firm seeks to invest in companies that can grow either organically or through a buy and build strategy. It mainly focuses on European market and midcap companies in Flanders and Brussels, and also invests in Kazakhstan, Benelux, Germany, France, Italy, Luxembourg, Netherlands, United Kingdom, Russia, Czech Republic, and Slovakia. Within consumer 2020, it focuses on consumer goods, food and beverage, healthy food, sport, convenience food, personal luxury, career, home & deco, baby & kids, pet products, retail, consumer services, media and content, travel and leisure, education, digital economy and online sectors. It invests in small and medium sized businesses primarily with headquarters in the Benelux, France, and Germany with an enterprise value of up to ?125 million ($144.76 million). It seeks to invest between ?3 million ($3.47 million) to ?30 million ($34.74 million). Within health and care sector, it focuses on life sciences, medtech, and health and care services. The firm focuses on biotech/biopharma comprising drugs, platform technologies, vaccines and diagnostic tests, preclinical, early clinical, and late clinical, medtech such as me Address: Karel Oomsstraat 37, Antwerp, Belgium, 2018
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service